Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)

Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU, Anders C, Hall P, Zaman K, Aebi S, Rossi L, Klint L, Killander F, Schiza A, del Prado PM, González CH, Flores EG, Sanchez CR, López RL, Castán JC, Borrego MR, Marti MPL, Gregori JG, Manich CS, Losada MJV, Sousa AR, Cardoso F, Simões J, Duchnowska R, Jassem J, Radecka B, Nowecki Z, Wysocki P, Sætersdal A, Engebråten O, Pilskog M, Houtsma D, de Boer M, Tomioka N, Tsugawa K, Tsurutani J, Yamashita T, Fotia V, Biganzoli L, Berardi R, Caruso M, De Laurentiis M, McCaffrey J, van Mackelenbergh M, Marmé F, Grischke EM, Braun M, Tio J, Park-Simon TW, Fasching P, Untch M, Tesch H, Reinisch M, Wimberger P, Huovinen R, Mattson J, Tanner M, Brix E, Rønlev J, Maraldo M, Chia S, Jerzak K, De Cuypere E, Collignon J, Gombos A, Murray N, Clay T, McCartney A, McCarthy N, Yeo B (2024)

Publication Type: Journal article, Erratum

Publication year: 2024

Journal

Book Volume: 30

Pages Range: 3780-

Journal Issue: 12

DOI: 10.1038/s41591-024-03349-0

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.

Authors with CRIS profile

Involved external institutions

Klinikum der Universität München (LMU Klinikum) Germany (DE) Hospital Universitario 12 de Octubre Spain (ES) Centre Hospitalier Universitaire de Liège (CHU Liège) Belgium (BE) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE) Tokai University / 東海大学 (Tōkai Daigaku) Japan (JP) European Institute of Oncology / Istituto Europeo di Oncologia (IEO) Italy (IT) Medizinische Universität Wien Austria (AT) Universitätsspital Basel Switzerland (CH) St Vincent's University Hospital Ireland (IE) University College Cork (UCC) Ireland (IE) Royal North Shore Hospital (RNSH) Australia (AU) Hospital Beata María Ana Spain (ES) University of Padua / Universita degli Studi di Padova Italy (IT) Ospedale San Raffaele (früher: Centro San Raffaele del Monte Tabor Foundation) Italy (IT) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven Belgium (BE) Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron Spain (ES) AstraZeneca UK Limited United Kingdom (GB) Duke University Medical Center United States (USA) (US) Ruber International Hospital Spain (ES) Hospital Universitario de La Princesa Spain (ES) Haukeland University Hospital / Haukeland universitetssykehus Norway (NO) HagaZiekenhuis Netherlands (NL) Maastricht University Netherlands (NL) Universitätsklinikum Münster Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE) Agaplesion Markus Krankenhaus Germany (DE) Kliniken Essen-Mitte Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden Germany (DE) Turku University Hospital / Turun yliopistollinen keskussairaala (TYKS) Finland (FI) HUSLAB Finland (FI) Tampere University Hospital / Tampereen yliopistollinen sairaala (TAYS) Finland (FI) Gentofte Hospital Denmark (DK) Odense Universitetshospital (OUH) Denmark (DK) Rigshospitalet Denmark (DK) GenesisCare Australia (AU) MonashHeart (formerly: Cardiology, Monash Medical Centre) Australia (AU) Austin Health Australia (AU) British Columbia Cancer Agency Canada (CA) Sunnybrook Health Sciences Centre Canada (CA) AZ Sint-Jan Belgium (BE) Institut Jules Bordet Belgium (BE) Dana-Farber Cancer Institute United States (USA) (US) Western General Hospital United Kingdom (GB) Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV) Switzerland (CH) Luzerner Kantonsspital (LUKS) Switzerland (CH) Ente Ospedaliero Cantonale Switzerland (CH) Sahlgrenska University Hospital / Sahlgrenska Universitetssjukhuset Sweden (SE) Skåne University Hospital / Skånes universitetssjukhus Sweden (SE) Uppsala University Hospital / Akademiska sjukhuset Sweden (SE) Hospital de Basurto Spain (ES) Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV) Spain (ES) Complejo Hospitalario Universitario de Granada Spain (ES) Complejo Hospitalario de Salamanca / Complejo Asistencial Universitario de Salamanca Spain (ES) Complejo Hospitalario Universitario de Santiago de Compostela Spain (ES) Hospitales Universitarios Virgen Macarena y Virgen del Rocío Spain (ES) Valencia Oncology Institute Foundation / Fundación Instituto Valenciano de Oncología / Fundació Institut Valencià d’Oncologia (IVO) Spain (ES) Bellvitge University Hospital / Hospital Universitari de Bellvitge Spain (ES) Hospital Clínic de Barcelona Spain (ES) Centro Hospitalar de Lisboa Central Portugal (PT) Champalimaud Foundation / Fundação Champalimaud Portugal (PT) Universidade do Porto Portugal (PT) Wojskowy Instytut Medyczny Poland (PL) Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu Poland (PL) Maria Skłodowska-Curie Institute of Oncology / Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie Poland (PL) Szpital Uniwersytecki w Krakowie Poland (PL) Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet Norway (NO) National Hospital Organization Hokkaido Medical Center / 独立行政法人 国立病院機構 北海道医療センター Japan (JP) St. Marianna University School of Medicine / 聖マリアンナ医科大学 Japan (JP) Showa University Hospitals Japan (JP) Kanagawa Prefectural Hospital / Kanagawa Cancer Center / 神奈川県立がんセンター Japan (JP) Azienda Ospedaliera Papa Giovanni XXIII Italy (IT) Ospedale Misericordia e Dolce Italy (IT) Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona Italy (IT) Humanitas Istituto Clinico Catanese Italy (IT) Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Italy (IT) Mater Misericordiae University Hospital (MMUH) / Ospidéal an Mater Misercordiae Ireland (IE) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Ruprecht-Karls-Universität Heidelberg Germany (DE) Universitätsklinikum Tübingen Germany (DE) Rotkreuzklinikum München Germany (DE) HELIOS Kliniken Germany (DE) St John of God Subiaco Hospital Australia (AU) Icon Group Australia (AU)

How to cite

APA:

Harbeck, N., Ciruelos, E., Jerusalem, G., Müller, V., Niikura, N., Viale, G.,... Yeo, B. (2024). Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7). Nature Medicine, 30(12), 3780-. https://doi.org/10.1038/s41591-024-03349-0

MLA:

Harbeck, Nadia, et al. "Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)." Nature Medicine 30.12 (2024): 3780-.

BibTeX: Download